We describe a 59-year- 
Introduction

Post-parathyroidectomy transient thyrotoxicosis (PTT) is a syndrome of spontaneously resolving thyrotoxicosis detected within two weeks after parathyroidectomy, suggesting that neck exploration could provide sufficient stimulation to release thyroid hormone from the thyroid (1). It has been reported that patients with PTT suffer from sweating, nervousness, palpitation, chest pain, heat intolerance, fatigue, and weight loss, but that the condition is self-limiting without treatment (2). The clinical significance of PTT has remained unclear. Atrial fibrillation (Af) is characterized by disorganized atrial electrical activation and uncoordinated atrial contraction. The atria do not contract effectively, thus promoting intra-atrial thrombosis. Patients with thyrotoxicosis have an increased risk of developing Af
, which may occur in 5-15% of affected patients, especially those over 60 years of age (4, 5) .
We report a 59-year-old woman who developed thyrotoxicosis and Af after total parathyroidectomy for secondary hyperparathyroidism due to chronic renal failure (CRF) g i n g s t u d y 1 2 d a y s a f t e r p a r at h y r o i d e c t o my s h o ws l o w u p t a k e o f 0 . 3 1 % ( n o r ma l r a n g e ,  0 . 4 -3 %) wi t h a n o r ma l -s h a p e d t h y r o i d g l a n (Fig. 1B) There are a number of causes of primary thyrotoxicosis, such as Graves' disease, painless thyroiditis, subacute thyroiditis, and functional thyroid nodule (6) . Graves' disease is believed to be mediated by TRAb or TSAb, which are generated as a result of intrathyroidal and peripheral immunoregulatory changes in T-lymphocytes and B-cells (7, 8) . (9, 10) . As noted previously, some patients with painless thyroiditis may have associated increases in the titers of TPOAb and TgAb, and may have pathogenetic mechanisms that are mediated by underlying autoimmune thyroiditis (9, 10) . Subacute thyroiditis is often associated with a viral etiology, has features of localized pain and swelling of the thyroid gland, and is often accompanied by fever (6) . In thyrotoxicosis induced by painless thyroiditis or subacute thyroiditis, lack of detectable uptake of radioactive material upon thyroid scintigraphy is a characteristic feature (6) . A functional thyroid nodule with autonomous production of thyroid hormone can be demonstrated by ultrasonographic examination, and thyroid scintigraphy shows an increased uptake of radioactive material by the nodule (6 
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. The patient was immediately referred to the division of cardiology. Direct current cardioversion was attempted to revert the Af to normal sinus rhythm. Emergency coronary angiography confirmed that the coronary arteries were normal. Thyroid function tests revealed a suppressed level of TSH (0.137 μU/mL), elevated levels of free triiodothyronine (FT 3) (5.35 pg/mL) and FT4 (2.59 ng/dL), and negative titers of all anti-thyroid antibodies, including anti-TSH receptor antibody (TRAb), thyroid stimulating antibody (TSAb), antithyroid peroxidase antibody ( TPOAb ) , and antithyroglobulin antibody (TgAb) (
The diagnostic features of Graves' disease include diffuse goiter, ophthalmopathy, a positive titer of TRAb or TSAb, and increased thyroid uptake of radioactive material with diffuse uptake on thyroid scintigraphy (6). Painless thyroiditis is an established cause of thyrotoxicosis that resolves spontaneously within several months; it is not associated with significant thyroidal pain or clinical or laboratory evidence of active inflammation
